Vascular effects dominate solid tumor response to treatment with combretastatin A-4-phosphate.
Vascular-targeted therapeutics are increasingly used in the clinic. However, less is known about the direct response of tumor cells to these agents. We have developed a combretastatin-A-4-phosphate (CA4P) resistant variant of SW1222 human colorectal carcinoma cells to examine the relative importance...
Main Authors: | , , , , , , , |
---|---|
格式: | Journal article |
语言: | English |
出版: |
2011
|